Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung disease with excess mucus and mucus plugs. We are focused on treating respiratory diseases with significant unmet need, such as COPD, cystic fibrosis and asthma.
Our technology was developed and spun out of Dr. John Fahy’s airway biology lab at University of California San Francisco (UCSF) in collaboration with Dr. Stefan Oscarson’s glycochemistry lab at University College Dublin and Dr. Anne Marie Healy’s pharmaceutics lab at Trinity College Dublin. The efforts of this research consortium led to over $18M in NIH grant funding, resulting in the identification of our lead therapeutic candidate (AER-01), establishment of preliminary safety and efficacy profiles, and the production of clinical trial API.
Location: United States, California, San Francisco
Employees: 1-10
Total raised: $51.882384M
Founded date: 2014
Investors 1
Date | Name | Website |
30.08.2023 | OrbiMed | orbimed.co... |
Funding Rounds 2
Date | Series | Amount | Investors | Deal News |
22.04.2023 | Series A | $36M | - | finsmes.co... |
22.12.2022 | - | $15.882384... | - | - |
Mentions in press and media 8
Date | Title | Description | Source |
22.04.2023 | BioSpace: Aer Therapeutics Raises $36M for Novel Approach to... | - | canaan.com... |
14.04.2023 | UCD spin-out Aer Therapeutics closes $36m funding round | Aer Therapeutics, a UCD biopharma spin-out developing inhaled treatments for lung diseases has close... | businesspl... |
14.04.2023 | Aer Therapeutics bags €32.7M to develop treatment for mucus-... | Aer Therapeutics, a biopharmaceutical spin-out company and a collaboration between University Colleg... | siliconcan... |
14.04.2023 | Aer Therapeutics Raises $36M in Series A Funding | Aer Therapeutics Logo Aer Therapeutics, a Raleigh, North Carolina-based biopharmaceutical company d... | finsmes.co... |
13.04.2023 | Aer Therapeutics Closes $36 Million Series A to Advance Deve... | - | orbimed.co... |
13.04.2023 | Aer Therapeutics Inks $36M Series A Round | RALEIGH, N.C., Aer Therapeutics, a biopharmaceutical company developing novel inhaled treatments f... | vcnewsdail... |
- | Aer Therapeutics | - | fastfounde... |
- | Biopharmaceutical Company Aer Therapeutics Raises $36 Millio... | Aer Therapeutics – a biopharmaceutical company developing novel inhaled treatments for muco-obstruct... | pulse2.com... |